AGE AND BODY MASS INDEX AS FACTORS OF FEMALE INFERTILITY AND NEGATIVE RESULTS OF ASSISTED REPRODUCTIVE TECHNOLOGIES


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

To improve the effective«ess of assisted reproductive tech«ologies is a key problem i« modern medici«e. Therapeutic approaches to reducmg the likelihood of «otgett'mgpreg«a«t are i«evitably associated with mfertility-related risk factors. Wome« with good reproductive health mostly become mothers «aturally, apart from bei«g influenced by the malefactor or resorti«g to medical decisio«s through perso«al reaso«s. Amo«g the sta«dard risk factors that lead to a decrease i« the effective«ess of assisted reproductive tech«ologies, there are obesity a«d late reproductive age. The paper considers the mecha«isms for the «egative effects of these features of the a«am«esis a«d the ways to reduce/overcome their harmful effects o« preg«a«cy. A« a«alysis of i«formatio« sources has identified the possibilities of increasing the effectiveness of the onset a«d preservatio« of induced preg«a«cy in the prese«ce of the above risk factors. It has bee« fou«d that it is «ecessary to orga«ize a comprehe«sive preparation of a womans health before reproductive intervention in order to «ormalize weight a«d the hormo«e backgrou«d. O«ly a cha«ge in lifestyle a«d consolidation of «ew behavior ca« sig«ifica«tly reduce the «egative impact of obesity o« a womans reproductive health. Treatment should be performed taki«g into accou«t co«comita«t diseases, in particular diabetes mellitus, polycystic ovary syndrome, etc. The successes of pharmacological treatment for obesity i« reduci«g the level of i«flue«ce of i«fertility a«d i« i«creasi«g the effective«ess of assisted reproductive tech«ologies are a«alyzed separately. Conclusion. It has been found that there are very few drugs that can be used to correct weight during pregnancy when planning due to side effects. Before planning a pregnancy at late reproductive age, there is a need for exhaustive analysis of the female reproductive system, including an evaluation of the ability to ovulate and the state of the endometrium. Exogenous hormonal background correction must be done. The negative effect of obesity or late reproductive age depends on many individual characteristics of the patient's history. Therefore, whether there is a prevalence of the influence of one or another factor in their combination remains unresolved and causes discussion.

Full Text

Restricted Access

About the authors

Abuduwaili Ruziguli

Saint Petersburg State Pediatric Medical University, Ministry of Health of Russia

Email: 2568141218@mail.ru
postgraduate student, Department of Obstetrics and Gynecology 194100, Russia, St. Petersburg, Litovskaya str., 2

Nikolai N. Rukhliada

Saint Petersburg State Pediatric Medical University, Ministry of Health of Russia

Email: 2568141218@mail.ru
Dr. Med. Sci., Head of the Department of Obstetrics and Gynecology 194100, Russia, St. Petersburg, Litovskaya str., 2

References

  1. Иакашвили С.Н., Самчук П.М. Особенности течения и исход одноплодной беременности, наступившей после экстракорпорального оплодотворения и переноса эмбриона, в зависимости от фактора бесплодия. Современные проблемы науки и образования. 2017; 3: 50
  2. Андреева Е.Н., Абсатарова Ю.С., Шереметьева Е.В., Фурсенко В.А. Ожирение и репродуктивная функция у женщин: эпигенетические и сомато-психологические особенности. Ожирение и метаболизм. 2019; 16(2): 9-15
  3. Пинхасов Б.Б. Патогенетические особенности первичного ожирения и его типов у женщин репродуктивного возраста. Международный эндокринологический журнал. 2011; 8: 13-26
  4. Setji T.L., Brown A.J. Polycystic ovary syndrome: update on diagnosis and treatment. Am. J. Med. 2014; 127(10): 912-9. https://dx.doi.org/10.1016/j. amjmed.2014.04.017.
  5. Karacan E., Caglar G.S., Gursoy A.Y., Yilmaz M.B. Body satisfaction and eating attitudes among girls and young women with and without polycystic ovary syndrome. J. Pediatr. Adolesc. Gynecol. 2014; 27(2): 72-7. https://dx.doi. org/10.1016/j.jpag.2013.08.003.
  6. Butterworth J., Deguara J., Borg C.M. Bariatric surgery, polycystic ovary syndrome, and infertility. J. Obes. 2016; 2016: 1871594. https://dx.doi. org/10.1155/2016/1871594.
  7. Shehata M. Effect of female increased body mass index on intracytoplasmic sperm injection outcome. Sci. J. Al-Azhar Med. Fac. Girls. 2017; 1(1): 36-41. https://dx.doi.org/10.4103/sjamf.sjamf_12_17.
  8. Григорян О.Р., Михеев Р.К., Андреева Е.Н., Дедов И.И. Овариальный резерв у женщин с ожирением. Ожирение и метаболизм. 2019; 16(3): 69-75.
  9. Teede H.J., Misso M.L., Costello M.F., Dokras A., Laven J., Moran L. et al. International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum. Reprod. 2018; 33(9): 1602-18. https://dx.doi.org/10.1093/ humrep/dey256.
  10. Foroozanfard F., Rafiei H., Samimi M., Gilasi H.R., Gorjizadeh R., Heidar Z. et al. The effects of dietary approaches to stop hypertension diet on weight loss, anti-Mullerian hormone and metabolic profiles in women with polycystic ovary syndrome: a randomized clinical trial. Clin. Endocrinol. (Oxf). 2017; 87(1): 51-8. https://dx.doi.org/10.1111/cen.13333.
  11. Guenard F., Deshaies Y., Cianflone K., Kral J.G., Marceau P., Vohl M.C. Differential methylation in glucoregulatory genes of offspring born before vs. after maternal gastrointestinal bypass surgery. Proc. Natl. Acad. Sci. USA. 2013; 110(28): 11439-44. https://dx.doi.org/10.1073/pnas.1216959110.
  12. Timmermans S., Steegers-Theunissen R.P., Vujkovic M., den Breeijen H., Russcher H., Lindemans J. et al. The Mediterranean diet and fetal size parameters: the Generation R Study. Br. J. Nutr. 2012; 108(8): 1399-409. https://dx.doi.org/10.1017/S000711451100691X.
  13. Dante G., Vaccaro V., Facchinetti F. Use of progestagens during early pregnancy. Facts Views Vis. Obgyn. 2013; 5(1): 66-71.
  14. Boudet-Berquier J., Salanave B., Desenclos J.C., Castetbon K. Sociodemographic factors and pregnancy outcomes associated with prepregnancy obesity: effect modification of parity in the nationwide Epifane birth-cohort. BMC Pregnancy Childbirth. 2017; 17(1): 273. https://dx.doi.org/10.1186/s12884-017-1456-8.
  15. Chen C.P. Prenatal findings and the genetic diagnosis of fetal overgrowth disorders: Simpson-Golabi-Behmel syndrome, Sotos syndrome, and Beckwith-Wiedemann syndrome. Taiwan. J. Obstet. Gynecol. 2012; 51(2): 186-91. https:// dx.doi.org/10.1016/j.tjog.2012.04.004.
  16. Hou M., Chu Z, Liu T., Lv H., Sun L., Wang B. et al. A high-fat maternal diet decreases adiponectin receptor-1 expression in offspring. J. Matern. Neonatal Med. 2015; 28(2): 216-21. https://dx.doi.org/10.3109/14767058.2014.914489.
  17. Frias A.E., Grove K.L. Obesity: a transgene rational problem linked to nutrition during pregnancy. Semin. Reprod. Med. 2012; 30(6): 472-8. https://dx.doi.org/10.1055/s-0032-1328875.
  18. Shen M., Chaudhry S.H., MacFarlane A.J., Gaudet L., Smith G.N., Rodger M.A. et al. Serum and red-blood-cell folate demonstrate differential associations with BMI in pregnant women. Public Health Nutr. 2016; 19(14): 2572-9. https:// dx.doi.org/10.1017/S1368980016000756.
  19. Diefenbach K., Trummer D., Ebert F., Lissy M., Koch M., Rohde B. EE-drospirenone-levomefolate calcium versus EE-drospirenone + folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment cessation. Int. J. Womens Health. 2013; 5: 149-63. https://dx.doi.org/ 10.2147/ IJWH.S37254.
  20. Vannuccini S., Clifton V.L., Fraser I.S., Taylor H.S., Critchley H., Giudice L.C. et al. Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome. Hum. Reprod. Update. 2016; 22(1): 104 https://dx.doi.org/10.1093/humupd/dmv044.
  21. Practice Committee of the American Society for Reproductive Medicine. The clinical relevance of luteal phase deficiency: a committee opinion. Fertil. Steril. 2012; 98(5): 1112-7. https://dx.doi.org/10.1016/j.fertnstert.2012.06.050.
  22. Keum N., Greenwood D.C., Lee D.H., Kim R., Aune D., Ju W. et al. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies. J. Natl. Cancer Inst. 2015; 107(2): djv088. https://dx.doi. org/10.1093/jnci/djv088.
  23. Benedetto C., Salvagno F., Canuto E.M., Gennarelli G. Obesity and female malignancies. Best Pract. Res. Clin. Obstet. Gynaecol. 2015; 29(4): 52840. https://dx.doi.org/10.1016/j.bpobgyn.2015.01.003.
  24. Gottschau M., Kjaer S.K., Jensen A., Munk C., Mellemkjaer L. Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study. Gynecol. Oncol. 2015; 136(1): 99-103. https://dx.doi.org/10.1016/j.ygyno.2014.11.012.
  25. Shafiee M.N., Khan G., Ariffin R., Abu J., Chapman C., Deen S., Nunns D., Barrett D.A., Seedhouse C., Atiomo W. Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: could metformin help? Gynecol. Oncol. 2014; 132(1): 248-53. https://dx.doi.org/10.1016/j.ygyno.2013.10.028.
  26. Anveden A., Taube M., Peltonen M., Jacobson P., Andersson-Assarsson J.C., Sjoholm K. et al. Long-term incidence of female-specific cancer after bariatric surgery or usual care in the Swedish Obese Subjects Study. Gynecol. Oncol. 2017; 145(2): 224-9. https://dx.doi.org/10.1016/j.ygyno.2017.02.036.
  27. Махмадалиева М.Р., Коган И.Ю., Ниаури Д.А., Мекина И.Д., Гзгзян А.М. Влияние избытка массы тела и ожирения на эффективность программ вспомогательных репродуктивных технологий. Журнал акушерства и женских болезней. 2018; 67(2): 32-9.
  28. Аншина М.Б., Подзолкова Н.М., Колода Ю.А., Шамугия Н.Л., Смирнова А.А., Абляева Э.Ш. Особенности индукции суперовуляции у пациенток с избыточной массой тела и ожирением. Проблемы репродукции. 2009; 15(1): 65-9
  29. Tomic V., Tomic J., Klaic D.Z., Kasum M., Kuna K. Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial. Eur. J. Obstet. Gynecol. Reprod. Biol. 2015; 186: 4953. https://dx.doi.org/ 10.1016/j.ejogrb.2014.11.002.
  30. Salehpour S., Tamimi M., Saharkhiz N. Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): a randomized clinical trial. Iran. J. Reprod. Med. 2013; 11(11): 913-8.
  31. Khoei H.H., Dehdehi L., Moloudizargari M., Baninameh Z., Rezaie-Chamani S., Conti G.O. et al. Female obesity and clinical outcomes of assisted reproductive technologies (ART): an updated systematic review and meta-analysis. Int. J. Med. Res. Health Sci. 2016; 5(11): 157-70.
  32. Practice Committee of the American Society for Reproductive Medicine. Obesity and reproduction: a committee opinion. Fertil. Steril. 2015; 104(5): 1116-26. https://dx.doi.org/10.1016/j.fertnstert.2015.08.018.
  33. Khairy M., Rajkhowa K. Effect of obesity on assisted reproductive treatment outcomes and its management: a literature review. Obstet. Gynaecol. 2017; 19(1): 47-54. https://dx.doi.org/10.1111/tog.12343.
  34. Бейк Е.П., Сыркашева А.Г., Долгушина Н.В. Эффективность программ вспомогательных репродуктивных технологий у пациенток позднего репродуктивного возраста. Гинекология. 2018; 20(1): 109-12.
  35. Ермоленко К.С., Радзинский В.Е., Рапопорт С.И. Современное состояние проблемы реализации фертильной функции женщин позднего репродуктивного возраста. Клиническая медицина. 2016; 94(1): 10-5
  36. Kasum M., Radakovic B., Simunic V., Oreskovic S. Preovulatory progesterone rise during ovarian stimulation for IVF. Gynecol. Endocrinol. 2013; 29(8): 7448. https://dx.doi.org/10.3109/09513590.2013.798280.
  37. Reiter R.J., Tan D.X., Korkmaz A., Rosales-Corral S.A. Melatonin and stable circadian rhythms optimize maternal, placental and fetal physiology. Hum. Reprod. Update. 2014; 20(2): 293-307. https://dx.doi.org/10.1093/humupd/ dmt054.
  38. Tamura H., Takasaki A., Taketani T., Tanabe M., Lee L., Tamura I. et al. Melatonin and female reproduction. J. Obstet. Gynaecol. Res. 2014; 40(1): 1-11. https://dx.doi.org/10.1111/jog.12177.
  39. Shi L., Li N., Bo L., Xu Z. Melatonin and hypothalamic-pituitary-gonadal axis. Curr. Med. Chem. 2013; 20(15): 2017-31. https://dx.doi.org/ 10.2174/ 09298673113209990114.
  40. Bhatti P., Mirick D.K., Davis S. The impact of chronotype on melatonin levels among shift workers. Occup. Environ. Med. 2014; 71(3): 195-200. https:// dx.doi.org/10.1136/oemed-2013-101730.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies